WHO ICTRP trial
Acute Myeloid Leukaemia (AML) Trial 12 (modified) for patients aged under 60
ISRCTN55678797 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN55678797 |
|---|---|
| Public title | Acute Myeloid Leukaemia (AML) Trial 12 (modified) for patients aged under 60 |
| Primary sponsor | Medical Research Council (MRC) (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Leukaemia (acute) Cancer Leukaemia |
| Interventions | Four randomised comparisons: At diagnosis: 1. S-DAT versus H-DAT 2. All-trans-retinoic acid (ATRA) versus not (except for acute promyelocytic leukaemia (APL) patients who will receive ATRA) After course 3: 3. 4 versus 5 courses of total… |
| Registration date | Aug 19, 2002 |
| Target size | 500 |
| Secondary IDs | MRC AML12 (modified) |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: